Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials

Product News   May 22, 2013

 
Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Related Product News

Merck Expands End-to-End Biodevelopment Capability

Product News

Two new process development centers in the U.S. and China, in addition to its established center in France, will enhance Merck's end-to-end biodevelopment capabilities.

READ MORE

Introducing the CellSeal Automated Thawing System

Product News

Cook Regentec and Asymptote announce the launch of the new system, providing users with complete control in the thawing of cryogenically frozen cells.

READ MORE

GE Healthcare Enhances Single-Use Manufacturing Facility

Product News

The expanded site will manufacture a range of single-use products, including cell growth bags, based on a newly developed film platform resulting from GE’s strategic alliance with Sealed Air.

READ MORE